Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sector of biopharmaceuticals, featuring promising progress throughout a variety of clinical and industrial purposes. With its structural similarity to The natural way derived human serum albumin, OsrHSA offers a safer, much more responsible option for therapeutic use,